Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11464 posts found.

Sanofi to cut insulin prices by 78% starting January 2024

March 17, 2023 Sales and Marketing

French pharmaceutical company Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 …
News

The Association of the British Pharmaceutical Industry suspends Novo Nordisk for two years

March 16, 2023 Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has suspended Danish pharmaceutical company Novo Nordisk after “serious breaches” of the …
News

Novo Nordisk to cut insulin prices by up to 75% in 2024

March 15, 2023 Sales and Marketing

Danish pharmaceutical company Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, …
News

Pfizer signs $43bn deal to buy Seagen

March 14, 2023 Sales and Marketing

Pharma giant Pfizer has signed a definitive merger agreement valued at $43bn to buy biotech firm Seagen.   US-based Seagen …
News

Sanofi to acquire Provention Bio in $2.9bn deal

March 13, 2023 Sales and Marketing

Sanofi has agreed to acquire Provention Bio as part of a $2.9bn deal that aims to improve the company’s portfolio …
News

Gilead Sciences wins $175m in ongoing HIV fraud case

March 13, 2023 Sales and Marketing

Gilead Sciences, a research-based biopharmaceutical company, has won again in the lawsuit levelled against clinics, prescribers, medical labs and pharmacies …
News

FDA makes unusual ‘misinformation’ comment on Lucira’s EUA for COVID-19 and flu test

March 10, 2023 Sales and Marketing

The FDA has made a rare comment about what happened at Lucira Health’s Emergency Use Authorization (EUA) filing for its …
News

GSK’s RSV vaccine ready to launch

March 9, 2023 Sales and Marketing

GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …
News

Funding to increase access to early phase clinical trials given to Yale Cancer Center

March 7, 2023 Sales and Marketing

Yale Cancer Center has announced it has received collaborative funding aiming to support and increase access to early phase clinical …
News

Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment

March 3, 2023 Sales and Marketing

US-based pharmaceutical company Eli Lilly has signed a small licensing deal with Belgian start-up Confo Therapeutics to allow them access …
News

Moderna to pay $400m to US government over new COVID-19 vaccine license

February 28, 2023 Sales and Marketing

Moderna, a leader in the development of COVID-19 vaccines, announced that it has paid the National Institute of Allergy and …
News

Stryker’s Q Guidance System received FDA clearance for cranial applications

February 20, 2023 Sales and Marketing

Stryker, a medical technology company, has announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from …
News

Sorrento Therapeutics’ subsidiary Scilex Holding Company acquires rights to acute migraine treatment

February 13, 2023 Sales and Marketing

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, has announced that it has acquired the rights to ELYXYBTM (celecoxib oral …
News

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

February 10, 2023 Sales and Marketing

AbbVie Inc has announced that it expects to see a 37% decline in sales of its flagship rheumatoid arthritis drug …
News

Garuda Therapeutics closes series B funding with $62m

February 9, 2023 Sales and Marketing

Cambridge-based Garuda Therapeutics announced it closed a $62m series B funding round to support its off-the-shelf, self-renewing blood stem cell …
News

Latest content

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023